Assurance labs, a potentially key part of the development of artificial intelligence for medtech industy use, are not part of the official regulatory process yet, which could raise questions for the US Food and Drug Administration as the technology pushes further into the industry.
Key Takeaways
-
The FDA’s AI regulatory process currently cannot oversee assurance labs that would help test the algorithms to ensure they are working as intended.
-
Troy...
AI models in development for medical product research and clinical practice are expected to need oversight before and after deployment to ensure they run as intended.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?